The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

SIMPLE SUMMARY: The investigation of predictive and prognostic markers is pivotal in patients affected by hepatocellular carcinoma treated with immune-checkpoint-inhibitors. Inflammation has a central role in hepatocellular carcinoma development and progression; however, its role in influencing outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammed, Ambreen, Fulgenzi, Claudia Angela Maria, Dharmapuri, Sirish, Pinter, Matthias, Balcar, Lorenz, Scheiner, Bernhard, Marron, Thomas U., Jun, Tomi, Saeed, Anwaar, Hildebrand, Hannah, Muzaffar, Mahvish, Navaid, Musharraf, Naqash, Abdul Rafeh, Gampa, Anuhya, Ozbek, Umut, Lin, Junk-Yi, Perone, Ylenia, Vincenzi, Bruno, Silletta, Marianna, Pillai, Anjana, Wang, Yinghong, Khan, Uqba, Huang, Yi-Hsiang, Bettinger, Dominik, Abugabal, Yehia I., Kaseb, Ahmed, Pressiani, Tiziana, Personeni, Nicola, Rimassa, Lorenza, Nishida, Naoshi, Di Tommaso, Luca, Kudo, Masatoshi, Vogel, Arndt, Mauri, Francesco A., Cortellini, Alessio, Sharma, Rohini, D’Alessio, Antonio, Ang, Celina, Pinato, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750517/
https://www.ncbi.nlm.nih.gov/pubmed/35008350
http://dx.doi.org/10.3390/cancers14010186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750517/
https://www.ncbi.nlm.nih.gov/pubmed/35008350
http://dx.doi.org/10.3390/cancers14010186

Ejemplares similares